| dc.contributor.author | Shoalimova Z.M., Jalilov Sh.Z., Sobirov A.B. | |
| dc.date.accessioned | 2023-05-07T17:58:49Z | |
| dc.date.available | 2023-05-07T17:58:49Z | |
| dc.date.issued | 2023 | |
| dc.identifier.issn | 2181-3388 | |
| dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/7641 | |
| dc.description.abstract | Based on the results of our study, we can conclude that MS is a risk factor for the development of CVC and mortality in patients with MS who have had AMI with ST segment elevation. | en_US |
| dc.language.iso | other | en_US |
| dc.publisher | СБОРНИК МАТЕРИАЛОВ международной научно-практической конференции «БОЛЕЗНИ СОВРЕМЕННОЙ ЦИВИЛИЗАЦИИ: МЕЖДИСЦИПЛИНАРНЫЕ ИССЛЕДОВАНИЯ»UZBEK JOURNAL OF CASE REPORTS 2023, Том 3. (Специальный выпуск) | en_US |
| dc.relation.ispartofseries | 2023, Том 3. (Специальный выпуск); | |
| dc.subject | metabolic syndrome (MS), acute coronary syndrome | en_US |
| dc.title | EFFECT OF METABOLIC SYNDROME ON CARDIOVASCULAR COMPLICATIONS IN PATIENTS WHO SURVIVED ACUTE CORONARY SYNDROME | en_US |
| dc.type | Thesis | en_US |